APP and Alzheimer disease: IRP2 plays a more important role in the regulation of iron homeostasis in AD; it can indirectly inhibit the deposition of Aβ by reducing the expression of APP and lead to pathological changes to tau proteins in neurons when iron homeostasis is abnormal, thus reducing neuronal damage (Li et al., 2022; Table 1).